Avatrombopag maleate
Product Specifications
CAS Number
677007-74-8
Target
STAT, ERK, Cytochromes P450, Others, Thrombopoietin Receptor
Related Pathways
JAK/STAT signaling, Metabolism, Stem Cells, MAPK, Others, Immunology/Inflammation
Bioactivity
Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel orally-active thrombopoietin (TPO) receptor agonist. AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501 may be useful in the treatment of patients with thrombocytopenia. Avatrombopag was first approved in 2018.
Smiles
OC(=O)\C=C/C(O)=O.OC(=O)C1CCN(CC1)c1ncc(cc1Cl)C(=O)Nc1nc(-c2cc(Cl)cs2)c(s1)N1CCN(CC1)C1CCCCC1
Molecular Formula
C33H38Cl2N6O7S2
Molecular Weight
765.72
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15256004 1 Vial
Lentiviral mouse Dxo shRNA (UAS) - Lentiviral mouseDxo shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 
A00355-1-Fluoro647 100 µg/Vial
Anti-NAV1 Antibody Picoband® Fluoro647 Conjugated
Sign In for Pricing
View Details 
130323 100 µL
NFATC2IP (Nuclear Factor Of Activated T-Cells, Cytoplasmic, Calcineurin-Dependent 2 Interacting Protein, FLJ14639, MGC126790, MGC138387) (Not for Export EU)
Sign In for Pricing
View Details